|
1
|
Nriagu JO and Nieboer E: Chromium in the
Natural and Human Environments. 1st edition. Wiley; New York:
1988
|
|
2
|
Katz SA and Salem H: The Biological and
Environmental Chemistry of Chromium. VCH Publishers; New York:
1994
|
|
3
|
Voitkun V, Zhitkovich A and Costa M:
Cr(III)-mediated crosslinks of glutathione or amino acids to the
DNA phosphate backbone are mutagenic in human cells. Nucleic Acids
Res. 26:2024–2030. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sathwara NG, Patel KG, Vyas JB, et al:
Chromium exposure study in chemical based industry. J Environ Biol.
28:405–408. 2007.PubMed/NCBI
|
|
5
|
Chun L, Hongzhang C and Zuohu L:
Adsorptive removal of Cr(VI) by Fe-modified steam exploded wheat
straw. Process Biochem. 39:541–545. 2004. View Article : Google Scholar
|
|
6
|
McBride HM, Neuspiel M and Wasiak S:
Mitochondria: more than just a powerhouse. Curr Biol. 16:R551–R560.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hodges NJ, Adám B, Lee AJ, Cross HJ and
Chipman JK: Induction of DNA-strand breaks in human peripheral
blood lymphocytes and A549 lung cells by sodium dichromate:
association with 8-oxo-2-deoxyguanosine formation and
inter-individual variability. Mutagenesis. 16:467–474. 2001.
View Article : Google Scholar
|
|
8
|
Costa M, Zhitkovich A and Toniolo P:
DNA-protein cross-links in welders: molecular implications. Cancer
Res. 53:460–463. 1993.PubMed/NCBI
|
|
9
|
Budhwar R, Das M, Bihari V and Kumar S:
Exposure estimates of chromeplaters in India: an exploratory study.
Biomarkers. 10:252–257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Medeiros MG, Rodrigues AS, Batoréu MC,
Laires A, Rueff J and Zhitkovich A: Elevated levels of DNA-protein
crosslinks and micronuclei in peripheral lymphocytes of tannery
workers exposed to trivalent chromium. Mutagenesis. 18:19–24. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhitkovich A, Lukanova A, Popov T, et al:
DNA-protein crosslinks in peripheral lymphocytes of individuals
exposed to hexavalent chromium compounds. Biomarkers. 1:86–93.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Quievryn G, Peterson E, Messer J and
Zhitkovich A: Genotoxicity and mutagenicity of
chromium(VI)/ascorbate-generated DNA adducts in human and bacterial
cells. Biochemistry. 42:1062–1070. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Flora S and Wetterhahn KE: Mechanisms
of chromium metabolism and genotoxicity. Life Chem Rep. 7:169–244.
1989.
|
|
14
|
Wei YD, Tepperman K, Huang M, Sartor MA
and Puga A: Chromium inhibits transcription from polycyclic
aromatic hydrocarbon-inducible promoters by blocking the release of
histone deacetylase and preventing the binding of p300 to
chromatin. J Biol Chem. 279:4110–4119. 2004. View Article : Google Scholar
|
|
15
|
Schnekenburger M, Talaska G and Puga A:
Chromium cross-links histone deacetylase 1-DNA methyltransferase 1
complexes to chromatin, inhibiting histone-remodeling marks
critical for transcriptional activation. Mol Cell Biol.
27:7089–7101. 2007. View Article : Google Scholar
|
|
16
|
Mattagajasingh SN and Misra HP: Mechanisms
of the carcinogenic chromium(VI)-induced DNA-protein cross-linking
and their characterization in cultured intact human cells. J Biol
Chem. 271:33550–33560. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ali SF, LeBel CP and Bondy SC: Reactive
oxygen species formation as a biomarker of methylmercury and
trimethyltin neurotoxicity. Neurotoxicology. 13:637–648.
1992.PubMed/NCBI
|
|
18
|
Valko M, Rhodes CJ, Moncol J, Izakovic M
and Mazur M: Free radicals, metals and antioxidants in oxidative
stress-induced cancer. Chem Biol Interact. 160:1–40. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu XR, Li HB, Gu JD and Li XY: Kinetics of
the reduction of chromium(VI) by vitamin C. Environ Toxicol Chem.
24:1310–1314. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chorvatovicová D, Ginter E, Kosinová A and
Zloch Z: Effect of vitamins C and E on toxicity and mutagenicity of
hexavalent chromium in rat and guinea pig. Mutat Res. 262:41–46.
1991.PubMed/NCBI
|
|
21
|
Stearns DM, Kennedy LJ, Courtney KD,
Giangrande PH, Phieffer LS and Wetterhahn KE: Reduction of
chromium(VI) by ascorbate leads to chromium-DNA binding and DNA
strand breaks in vitro. Biochemistry. 34:910–919. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szablewski L, Sobczyk-Kopcioł A, Oleszczak
B, Mrozikiewicz-Rakowska B, Karnafel W and Grytner-Zięcina B:
Expression of glucose transporters in peripheral blood cells in
patients with type 2 diabetes mellitus depending on the mode of
therapy. Diabetologia Doświadczalna i Kliniczna. 7:204–212.
2007.
|
|
23
|
Piątkiewicz P, Czech A, Tatoń J and Górski
A: Investigations of cellular glucose transport and its regulation
under the influence of insulin in human peripheral blood
lymphocytes. Endokrynol Pol. 61:182–187. 2010.PubMed/NCBI
|
|
24
|
Cinatl J Jr, Cinatl J, Driever PH, et al:
Sodium valproate inhibits in vivo growth of human neuroblastoma
cells. Anticancer Drugs. 8:958–963. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhitkovich A and Costa M: A simple,
sensitive assay to detect DNA-protein crosslinks in intact cells
and in vivo. Carcinogenesis. 13:1485–1489. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brustovetsky N, Brustovetsky T, Jemmerson
R and Dubinsky JM: Calcium-induced cytochrome c release from CNS
mitochondria is associated with the permeability transition and
rupture of the outer membrane. J Neurochem. 80:207–218. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Emaus RK, Grunwald R and Lemasters JJ:
Rhodamine 123 as a probe of transmembrane potential in isolated
rat-liver mitochondria: spectral and metabolic properties. Biochim
Biophys Acta. 850:436–448. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhitkovich A, Voitkun V, Kluz T and Costa
M: Utilization of DNA-protein cross-links as a biomarker of
chromium exposure. Environ Health Perspect. 106(Suppl 4): 969–974.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li CJ, Zhang QM, Li MZ, Zhang JY, Yu P and
Yu DM: Attenuation of myocardial apoptosis by alpha-lipoic acid
through suppression of mitochondrial oxidative stress to reduce
diabetic cardiomyopathy. Chin Med J (Engl). 122:2580–2586.
2009.PubMed/NCBI
|
|
31
|
Shaham J, Bomstein Y, Gurvich R,
Rashkovsky M and Kaufman Z: DNA-protein crosslinks and p53 protein
expression in relation to occupational exposure to formaldehyde.
Occup Environ Med. 60:403–409. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jennette KW: The role of metals in
carcinogenesis: biochemistry and metabolism. Environ Health
Perspect. 40:233–252. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Connett PH and Wetterhahn KE: Metabolism
of the carcinogen chromate by cellular constituents. Struct
Bonding. 54:93–124. 1983. View Article : Google Scholar
|
|
34
|
Michaelson-Richie ED, Loeber RL, Codreanu
SG, et al: DNA-protein cross-linking by 1,2,3,4-diepoxybutane. J
Proteome Res. 9:4356–4357. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barker S, Weinfeld M and Murray D:
DNA-protein crosslinks: their induction, repair, and biological
consequences. Mutat Res. 589:111–135. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oleinick NL, Chiu SM, Ramakrishnan N and
Xue LY: The formation, identification, and significance of
DNA-protein cross-links in mammalian cells. Br J Cancer. (Suppl 8):
135–140. 1987.PubMed/NCBI
|
|
37
|
Taioli E, Zhitkovich A, Toniolo P and
Costa M: Normal values of DNA-protein crosslinks in mononuclear
cells of a population of healthy controls. Cancer J. 8:76–79.
1995.
|
|
38
|
Xu X, Muller JG, Ye Y and Burrows CJ:
DNA-protein cross-links between guanine and lysine depend on the
mechanism of oxidation for formation of C5 vs C8 guanosine adducts.
J Am Chem Soc. 130:703–709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bjorklund CC and Davis WB: Stable
DNA-protein cross-links are products of DNA charge transport in a
nucleosome core particle. Biochemistry. 46:10745–10755. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Giorgi C, Romagnoli A, Pinton P and
Rizzuto R: Ca2+ signaling, mitochondria and cell death.
Curr Mol Med. 8:119–130. 2008.
|
|
41
|
Nisoli E, Clementi E, Moncada S and
Carruba MO: Mitochondrial biogenesis as a cellular signaling
framework. Biochem Pharmacol. 67:1–15. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Son YO, Hitron JA, Wang X, et al: Cr(VI)
induces mitochondrial-mediated and caspase-dependent apoptosis
through reactive oxygen species-mediated p53 activation in JB6 CI41
cells. Toxicol Appl Pharmacol. 245:226–235. 2010. View Article : Google Scholar
|
|
43
|
Szabó I and Zoratti M: The mitochondrial
megachannel is the permeability transition pore. J Bioenerg
Biomembr. 24:111–117. 1992.PubMed/NCBI
|
|
44
|
Gottlieb E, Armour SM, Harris MH and
Thompson CB: Mitochondrial membrane potential regulates matrix
configuration and cytochrome c release during apoptosis. Cell Death
Differ. 10:709–717. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tuma DJ, Thiele GM, Xu D, Klassen LW and
Sorrell MF: Acetaldehyde and malondialdehyde react together to
generate distinct protein adducts in the liver during long-term
ethanol administration. Hepatology. 23:872–880. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xiao F, Feng X, Zeng M, Guan L, Hu Q and
Zhong C: Hexavalent chromium induces energy metabolism disturbance
and p53-dependent cell cycle arrest via reactive oxygen species in
L-02 hepatocytes. Mol Cell Biochem. 371:65–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xiao F, Li Y, Dai L, et al: Hexavalent
chromium targets mitochondrial respiratory chain complex I to
induce reactive oxygen species-dependent caspase-3 activation in
L-02 hepatocytes. Int J Mol Med. 30:629–635. 2012.
|
|
48
|
Hemminki K, Partanen R, Koskinen H, Smith
S, Carney W and Brandt-Rauf PW: The molecular epidemiology of
oncoproteins. Serum p53 protein in patients with asbestosis. Chest.
109(3 Suppl): 22S–26S. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hanaoka T, Yamano Y, Katsuno N, Kagawa J
and Ishizu S: Elevated serum levels of pantropic p53 proteins in
chromium workers. Scand J Work Environ Health. 23:37–40. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kortenkamp A, Curran B and O’Brien P:
Defining conditions for the efficient in vitro cross-linking of
proteins to DNA by chromium(III) compounds. Carcinogenesis.
13:307–308. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Macfie A, Hagan E and Zhitkovich A:
Mechanism of DNA-protein cross-linking by chromium. Chem Res
Toxicol. 23:341–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Voitkun V and Zhitkovich A: Analysis of
DNA-protein crosslinking activity of malondialdehyde in vitro.
Mutat Res. 424:97–106. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Singh J, Carlisle DL, Pritchard DE and
Patierno SR: Chromium-induced genotoxicity and apoptosis:
relationship to chromium carcinogenesis (review). Oncol Rep.
5:1307–1318. 1998.PubMed/NCBI
|
|
54
|
Bianchi V, Celotti L, Lanfranchi G, et al:
Genetic effects of chromium compounds. Mutat Res. 117:279–300.
1983. View Article : Google Scholar
|
|
55
|
Merk O and Speit G: Significance of
formaldehyde-induced DNA-protein crosslinks for mutagenesis.
Environ Mol Mutagen. 32:260–268. 1998. View Article : Google Scholar : PubMed/NCBI
|
